Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Most patients improved with oral contraceptives, but some needed additional treatment.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Flaxseed crackers can help reduce symptoms of PCOS in young women.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.